MustGrow Biologics Corp. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 0.001308 million compared to CAD 0.012869 million a year ago. Net loss was CAD 2.13 million compared to CAD 0.696115 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.02 a year ago.
For the nine months, sales was CAD 0.006479 million compared to CAD 0.012869 million a year ago. Net loss was CAD 4.56 million compared to CAD 1.97 million a year ago. Basic loss per share from continuing operations was CAD 0.09 compared to CAD 0.05 a year ago.